The potential benefits to society of treating latediagnosed mentally retarded persons with phenylketonuria were investigated. In order to ascertain the effects of late dietary intervention, the charts of 124 adults with PKU seen in the metabolic service at the Childrens Hospital of Los Angeles were reviewed. Fifty-nine were diagnosed later than 3 months of age and were over the age of 18 years. They were followed up with medical, psychological, and nutritional assessments. Genotyping was also performed. Twenty-eight have remained on a phenylalanine-restricted diet during the intervening years. All but 3 of the 28 latediagnosed PKU persons who remained on a restricted diet showed significant intellectual improvement. Seven are able to attend college, 9 are employed, and 12 are attending workshops and/or day care programs. The result of treatment with the phenylalanine-restricted diet was that these individuals could participate in society and were able to arrest the neurodegenerative course characteristic of persons with mutations classified as severe in the phenylalanine hydroxylase gene. We conclude that society could benefit substantially by providing a phenylalaninerestricted diet for late-diagnosed mentally retarded persons with phenylketonuria. Eighteen of 28 such persons who otherwise would have required residential care are living independently.
The phenylalanine (Phe)-restricted diet for the treatment of children with phenylketonuria (PKU) was introduced by Bickel et al. (1) in 1953 and has remained the single most effective therapeutic strategy for treating this disorder (2) . However, in 1963 Horner et al. (3) suggested that termination of this diet was feasible and through the 1960s and 1970s the discontinuation of dietary treatment was practiced widely. It was not until the Collaborative Study, funded by the National Institute of Child Health and Human Development, provided substantial evidence that diet discontinuation by 6 years was harmful to academic achievement (4), thereby supporting the earlier reports by Cabalska et al. (5) and Waisbren et al. (6) . By the 1980s most PKU centers throughout the world moved to a "diet for life" philosophy (7) . During these 40 years there has been little study of late-treated PKU individuals now living chiefly in the community (8) . Despite this, dietary treatment has been attempted in nearly all late-diagnosed individuals in the PKU program at Childrens Hospital of Los Angeles. Some have shown gratifying progress, while in others improvement has been minimal. To investigate what factors promote significant improvement, it was decided to do a follow-up study on all late-diagnosed adults.
METHODS AND PROCEDURES
The records of the PKU Program from the Children's Hospital of Los Angeles were reviewed and all adults with diagnostic blood phenylalanine levels consistently greater than 900 mol/liter (15 mg%) were included for review. The follow-up included clinical and biochemical assessments, genotyping, and nutritional, psychological, and socioeconomic evaluations. Genotyping was carried out at the Kennedy Child Study Center in Glostrup, Denmark, utilizing procedures already published (9) . Dietary control was arbitrarily classified as good if 75% of recorded blood phenylalanine levels were less than 720 mol/liter (15 mg%); fair if only 50% of recorded levels were less than 720 mol/liter (15 mg%); and poor if 75% of recorded levels were above 720 mol/ liter (15 mg%). Psychological assessments were performed, using developmental testing for those younger than 3 years of age and Stanford Binet for older children. The Wechsler Adult Intelligence Scale-Revised (WAIS-R) was utilized for adults. The Hollingshead Scale (HS) was utilized for socioeconomic assessment (10) . Blood phenylalanine levels were determined by the McCaman and Robins fluorometric method (11) .
The records of 124 individuals were reviewed. Sixty-one were excluded because they had been diagnosed by newborn screening. Six were lost to followup. Fifty-seven had been diagnosed between 3 months and 43 years of age, as they were born prior to newborn screening or were missed on screening due to various reasons. Twenty-one of these individuals were referred to Childrens Hospital of Los Angeles because of mental retardation and were identified as PKU. They are all still on a phenylalaninerestricted diet. Seven others were diagnosed as PKU elsewhere, but were then referred for treatment. These 28 are listed in Table 1 and are the main focus of this report. Eight other mentally retarded persons discontinued the diet for a variety of reasons and 15 individuals have remained off diet after having been treated for a number of years. Six were never treated.
The mutations were categorized, utilizing genotypes, as severe (S) or mild (M) (9, 12) . Genotypephenotype relationships were evaluated as in previously published reports (13) (14) (15) (16) (17) . Table 1 details the sex, age, diagnostic blood phenylalanine level, genotype, age of diagnosis, DQ/IQ, WAIS-R IQ at latest age after diagnosis, dietary control, years on diet, educational achievement, work history, and marital and socioeconomic status, as measured by the Hollingshead Scale. Eighteen were female, and 10 male with a mean age of 28 years. The mean diagnostic phenylalanine level for all was 1800 mol/liter (30 mg%), which is characteristic of the fact that 44 phenylalanine hydroxylase mutations are severe. The mean age of diagnosis was 8 years, with a range of 3 months to 44 years and the mean DQ/IQ at diagnosis was 44, with a range of not measurable (NM) to 100, compared to a mean on the latest Wechsler Adult Intelligence Scale of 73 (range NM to 108).
RESULTS
The quality of dietary control was good in 12, whose current WAIS-R mean score was 82 with a range of 40 -108. The 9 with fair control exhibited a mean score of 77 (range 59 -88) and the 7 with poor control scored a mean of 61 (range NM-88). The 28 subjects' mean years of treatment was 22 years, representing $6000 per person/year of treatment (total expenditure is in the range of $3,700,000 -$4,000,000). Educational achievement varied widely, ranging from none to college graduation. Four never attended school, 3 attended elementary school in special education classes, 11 attended high school special education classes, 3 attended normal high schools, and 7 attended college.
In terms of work, 9 of the 28 are employed, 6 are currently students in college, 3 attend a workshop, and 10 have never worked. Five females and 4 males are married. Seven children have been born to these 9 couples: 5 to 3 PKU women. One of the offspring is gifted; however, another expired during infancy due to a hypoplastic left heart defect. The pregnancy was complicated by poor control of blood phenylalanine levels during the first 4 months.
The socioeconomic status of the parents of these 28 subjects ranged from 1 to 5 on the Hollingshead Scale with a mean of 3.2. HS scores 1 and 2 (the highest) involved 7 PKU adults with a mean IQ of 91, 4 of whom exhibited good control of blood phenylalanine levels, 2 fair and 1 poor. There were 12 PKU adults, who exhibited a mean WAIS-R score of 77 with a range of NM-108 living in HS 3 families. The adults in HS Group 4 exhibited a mean WAIS-R score of 70 and Group 5 (lowest), 46, respectively. Only 1 of these 8 had good control, 2 fair, and 6 poor control. The late onset of treatment was also a factor in poor control of blood phenylalanine levels. The eight subjects treated by 1 In those treated after 7 years of age, the drop in IQ was marked. These subjects had a mean IQ of 43 (range of NM-78). Table 2 details the data on the 8 subjects who were diagnosed late (ages 0.25-1 1 2 years) and discontinued dietary therapy completely at ages 5-14 years and then resumed dietary treatment at 19 to 40 years of age. The reason for dietary resumption was a diagnosis of mental illness in 4, recurrent headaches resembling migraine in 1, desire for pregnancy in 2, and medical advice because of cerebral MRI changes in 1. Two (Cases 34 and 35) had one mild genotype and the other were all severe. Six exhibited an R to W mutation (R158W, R252W, R408W) and of these, 3 were associated with mental illness. The diagnostic blood phenylalanine level revealed a mean of 1860 mol/liter (31 mg%) in the 6 with two severe alleles at the PAH gene and 1260 mol/liter (21 mg%) in the 2 with one severe and one mildly affected allele (Cases 34 and 35). WAIS-R scores for the homozygous severe mutations, 6 adults demonstrated a mean of 85 (range 78 -97) and the 2 with heterozygous severe/mild affected alleles exhibited a mean IQ of 106 (range 102-110). Table 3 delineates the data for the 15 adults who were diagnosed late, discontinued dietary therapy, and never resumed a restricted phenylalanine regi- Table 4 consists of 6 adults who have never been treated with a phenylalanine-restricted diet. Their mean age at diagnosis was 4.3 years and the mean diagnostic blood Phe level was 1440 mol/liter (24 mg%). The DQ/IQ level at the time of diagnosis was 43, compared to a recent WAIS-R IQ score of 18. Individual 55 is married and is the brother of Case 37 discussed later. Except for this individual, none of the others are married or have been able to participate in any formal education. Their mean age at present is 36 years with a range of 33-50. Individual 56 lives at home and the other four live in an institutional setting, representing a total of 120 years.
DISCUSSION
Our review of these 57 subjects is divided into four different treatment groups: (1) 28 treated continuously to date (Table 1) ; (2) 8 treated and then dietary restrictions suspended for a number of years and (Table 3) ; and (4) 6 who were never treated (Table 4) . Despite the variation among individuals within these groups, certain conclusions are apparent. Mutation analysis revealed that 79% of the mutant alleles are considered severe and classified as null mutations. Only eight (16%) alleles were mild, which is a classification indicating in vivo PAH activity (Table 5) . Thus it would appear that in PKU persons, mental retardation occurs throughout the spectrum of severe and mild mutations and perhaps reflects the fact that brain development is more sensitive to hyperphenylalaninemia during the early years of life. These data suggest that early diagnosis and institution of therapy with good blood level control are essential to an optimum outcome.
In terms of dietary control, quality of treatment was very important (Table 6 ). For 11 subjects with good control, the mean WAIS-R IQ was 82 regardless of age of diagnosis. The 10 with fair control demonstrated a mean IQ of 77 on the WAIS-R and the 7 with poor control only 61. The data also reveal that the mean WAIS-R IQ was 82, with a range of 69 -108, on all subjects treated more than 19 years. Individual 11 (Fig. 1) demonstrates a slow progressive rise from a DQ of 66 to 98 in a man on treatment for 35.5 years. He has been steadily employed, is married, and has one normal child. His mother is a nurse and was largely responsible for his maintaining good control over the years, despite two severe mutations and limited tolerance for phenylalanine in his daily diet of less than 10 mg/kg/day. Finally, there is no question that socioeconomic status (18, 19) (Table 7) plays an important role in early diagnosis and in fostering good control of blood phenylalanine during prolonged treatment. HS of 1 and 2 indicating a professional and executive achievement of the parents resulted in a mean WAIS-R IQ of 91. HS scores of Group 3 in 12 subjects resulted in a drop in mean IQ to 77, scores of 4 in 5 subjects resulted in a mean WAIS-R score of 70, and an HS score of 5 resulted in a significant drop in WAIS-R IQ to 46.
There has been a suggestion by Fisch et al. (20) and Schuler et al. (21) that R408W is a mutation that may predispose to mental illness. Pietz et al. have also suggested that depression is more common in PKU persons (22) . While the data are limited, it is interesting that only 1 of these 28 treated individuals developed mental illness and did not exhibit the R408W mutation. However Table 2 also tends to support Schuler's hypothesis.
In Table 3 , Individual 37 is of interest. That individual is severely mentally retarded, whereas the older brother (Individual 55 on Table 4 ) is very bright with an IQ of 127 at 31 years of age without treatment. The mutation on one affected allele is deletion of I94 and his blood phenylalanine levels range between 900 and 1080 mol/liter (15-18 mg%). He is married, has one child, and is employed as a manager of a recycling business. Unfortunately the second PAH mutation is unidentified (23) .
In summary, the experience reported herein strongly supports treatment of persons with PKU who are diagnosed late. Adults with severe mutations on both PAH alleles account for most of the individuals studied. Whether analysis depicting the mutation R408W in persons off dietary therapy predisposes to mental illness remains unclear. The phenylalanine-restricted diet with good quality control of blood phenylalanine levels within the recommended range for adults of 120 -720 mol/liter (2-12 mg%) over a period of years is beneficial to intellectual achievement with higher education and stable living arrangements. 
